Literature DB >> 708015

Inactivation of metronidazole by anaerobic and aerobic bacteria.

E D Ralph, D A Clarke.   

Abstract

The rate of inactivation of metronidazole in vitro was determined during the course of time-kill curves against anaerobic and aerobic bacteria in the stationary phase of growth. Metronidazole at a concentration of 10 mug/ml, as measured by bioassay, was rapidly inactivated in broth culture by susceptible anaerobic bacteria (minimum bactericidal concentration </= 3 mug/ml), and this correlated closely with its bactericidal activity. In contrast, the drug was neither inactivated nor had any bactericidal activity against a resistant strain of Propionibacteriumacnes (minimum bactericidal concentration > 1,500 mug/ml). Three of four aerobic bacteria also inactivated metronidazole, although at generally slower rates than the anaerobes, but this was not associated with a bactericidal effect against these organisms. The presence of aerobic bacteria in mixed cultures with Bacteroides fragilis did not, moreover, inhibit the bactericidal activity of metronidazole against the latter organism. However, the possibility still remains that, in vivo, aerobic bacteria capable of inactivating metronidazole could inhibit the action of the drug against anaerobes in mixed infections.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708015      PMCID: PMC352468          DOI: 10.1128/AAC.14.3.377

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Antimicrobial activity of metronidazole in anaerobic bacteria.

Authors:  F P Tally; B R Goldin; N Sullivan; J Johnston; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

2.  Interaction of metronidazole with nucleic acids in vitro.

Authors:  N F LaRusso; M Tomasz; M Müller; R Lipman
Journal:  Mol Pharmacol       Date:  1977-09       Impact factor: 4.436

3.  Treatment with metronidazole of 48 patients with serious anaerobic infections.

Authors:  H Giamarellou; K Kanellakopoulou; D Pragastis; N Tagaris; G K Daikos
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

4.  The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms.

Authors:  R M Ings; J A McFadzean; W E Ormerod
Journal:  Biochem Pharmacol       Date:  1974-05-01       Impact factor: 5.858

5.  Pharmacokinetics of metronidazole as determined by bioassay.

Authors:  E D Ralph; J T Clarke; R D Libke; R P Luthy; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

6.  Further observations on strain sensitivity of Trichomonas vaginalis to metronidazole.

Authors:  J A McFadzean; I M Pugh; S L Squires; J P Whelan
Journal:  Br J Vener Dis       Date:  1969-06

7.  Treatment of anaerobic infections with metronidazole.

Authors:  F P Tally; V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

8.  Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens.

Authors:  E D Ralph; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

9.  Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.

Authors:  D G Lindmark; M Müller
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

10.  Metronidazole versus anaerobes. In vitro data and initial clinical observations.

Authors:  F P Tally; V L Sutter; S M Finegold
Journal:  Calif Med       Date:  1972-12
View more
  19 in total

1.  Recalcitrant vaginal trichomoniasis.

Authors:  R S Pattman
Journal:  Sex Transm Infect       Date:  1999-04       Impact factor: 3.519

2.  Failure of mebendazole to cure trichomonal vaginitis resistant to metronidazole: case reports.

Authors:  R S Pattman; M S Sprott; A M Kearns; M Earnshaw
Journal:  Genitourin Med       Date:  1989-08

Review 3.  Clinical pharmacokinetics of metronidazole.

Authors:  E D Ralph
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

4.  Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.

Authors:  F Soriano; M C Ponte; M C Gaspar
Journal:  J Clin Pathol       Date:  1982-10       Impact factor: 3.411

5.  Relationship between metronidazole metabolism and bactericidal activity.

Authors:  E J Chrystal; R L Koch; M A McLafferty; P Goldman
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

6.  Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.

Authors:  W R Heizmann; F Heilmann; B Egeler; H Werner
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

7.  Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report.

Authors:  J Kulda; M Vojtĕchovská; J Tachezy; P Demes; E Kunzová
Journal:  Br J Vener Dis       Date:  1982-12

8.  [Antibiotic resistance of anaerobic bacteria (author's transl)].

Authors:  W Niederau; U Höffler; G Pulverer
Journal:  Infection       Date:  1982       Impact factor: 3.553

Review 9.  Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.

Authors:  D I Edwards
Journal:  Br J Vener Dis       Date:  1980-10

10.  Metronidazole in treatment against Haemophilus vaginalis (Corynebacterium vaginale).

Authors:  E D Ralph; Y E Amatnieks
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.